To the full analysis
Omnicom Group stock: growth
OMCOmnicom Group reported $17.27B in revenue for fiscal 2025, up 10.1% on the prior year, up 5.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
2.2%
per year from 2006 to 2025, per share 5.1%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
3.1%
per year from 2006 to 2025, per share 6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 5.6% | 1.3% | 2.2% |
| Revenue per share | 7.0% | 3.3% | 5.1% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | 11.1% | 3.5% | 3.1% |
| Free cash flow per share | 12.5% | 5.5% | 6.0% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $11.38B | $864M | $1.56B |
| 2007 | $12.69B | $975.7M | $1.38B |
| 2008 | $13.36B | $1B | $1.18B |
| 2009 | $11.72B | $793M | $1.6B |
| 2010 | $12.54B | $827.7M | $1.33B |
| 2011 | $13.87B | $952.6M | $1.13B |
| 2012 | $14.22B | $998.3M | $1.23B |
| 2013 | $14.58B | $991.1M | $1.6B |
| 2014 | $15.32B | $1.1B | $1.26B |
| 2015 | $15.13B | $1.09B | $1.97B |
| 2016 | $15.42B | $1.15B | $1.77B |
| 2017 | $15.27B | $1.09B | $1.87B |
| 2018 | $15.29B | $1.33B | $1.53B |
| 2019 | $14.95B | $1.34B | $1.75B |
| 2020 | $13.17B | $951.2M | $1.65B |
| 2021 | $14.29B | $1.4B | $1.28B |
| 2022 | $14.29B | $1.3B | $848.3M |
| 2023 | $14.69B | $1.39B | $1.34B |
| 2024 | $15.69B | $1.48B | $1.59B |
| 2025 | $17.27B | −$54.5M | $2.79B |
Revenue by segment
How Omnicom Group Inc. makes its money and how that has shifted. Names are as the company reports them.
- Advertising$10.0B58%
- Public relations$1.6B9%
- Health Care$1.4B8%
- Experiential$862.7M5%
- Other$3.4B20%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies. The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Advertising | $10.02B | 58% |
| Public relations | $1.61B | 9.3% |
| Health Care | $1.38B | 8% |
| Experiential | $862.7M | 5% |
| Other | $3.4B | 19.7% |
| Total revenue | $17.27B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.